Effective 1 March 2021, Sandra Heskamp has been appointed professor of Nuclear Imaging and Therapy in Immuno-oncology at Radboud university medical center/Radboud University. She investigates the behavior of cancer cells through imaging to improve treatment for cancer patients. She is the youngest female professor in the history of Radboud university medical center.
As a biomedical researcher, Sandra Heskamp became fascinated by the complexity of tumors during her studies. In her research, she uses nuclear imaging because it offers unique opportunities to investigate the behavior of cancer cells and the tumor microenvironment in living humans and animals. She also develops new radioactively labeled molecules to specifically irradiate tumors. In her research, she uses the combination of nuclear imaging and therapy to improve treatment of cancer patients in a personalized manner.
Sandra Heskamp actively makes science accessible to the general public. She regularly explains her research to children during the 'Scientist in the Classroom' project. She has broad interests that go beyond her own field of study and thus inspires other scientists and appeals to a wide audience. She is a Principal Investigator at the Radboudumc, has won the KWF Bas Mulder Award for her research into the effective application of immunotherapy and has herself cycled up the Alpe d'Huez six times during Alpe d'Huzes to raise money for cancer research. She also received a VENI grant from the NWO.
In 2019, she received the X2 Ambition Award: This award is intended for emerging female scientists: young, ambitious women in a phase of their career where they are making important choices in their careers. This award is specifically for women who are role models both inside and outside their organizations. At 35 years, 5 months and 3 days, she is the youngest female professor appointed at Radboud university medical center.
Receptor-tyrosine kinases in cancer
Sandra Heskamp (1985, Enschede) studied at Radboud University in Nijmegen. She obtained her foundation degree in Medicine, and then switched to Biomedical Sciences. There her fascination for science started, and after finishing her study she became a PhD student at the Department of Nuclear Medicine in the Radboud university medical center. She investigated nuclear imaging of receptor tyrosine kinases: receptors that are important in cellular processes, but also play a crucial role in the development and progression of cancer (title thesis: ‘Molecular imaging of receptor tyrosine kinases in cancer’).
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
ZonMw Open Competition Grant for Annemiek van Spriel and Piet Gros15 June 2021
Annemiek van Spriel, theme cancer development and immune defense, together with Piet Gros, Dept. of Chemistry, Utrecht University obtained a ZonMw Open Competition Grant to investigate IL-6 receptor structure and signalling in tumor cells.read more
Human microbiome could shed light on higher morbidity rate in minoritized populations The link between environmental inequities and disease may lie in the gut15 June 2021
A study published in PNAS is the first to explicitly address the gut microbiome as a pathway to understanding how environmental inequities could lead to health disparities.read more
New ultra-high field MRI system available for Radboudumc and Radboud University10 June 2021
Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.read more
On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis10 June 2021
Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.read more
Retina-on-chip modeling and treating eye diseases in a dish10 June 2021
Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.read more
New method to prevent ovarian cancer increases quality of life8 June 2021
Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.read more